éå»1ã¶æéã«Cartesian Therapeutics Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã7åã«åºã¥ãããŒã¿ã
仿ãRNACã¯4ä»¶ã®ãè²·ããã0ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããRNACã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯33.667ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS 0.466ã«ç¶ããRNACã®FY2026Q3ã®EPSã¯-0.940ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD 0.47 ã§ããããCartesian Therapeutics IncRNAC ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -1.46 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -0.94 ãšäºæ³ãããŸãã